Background and Purpose: Cystic Fibrosis (CF) is caused by mutations in the CF Transmembrane
Introduction
Cystic Fibrosis (CF), a life-threatening recessive disorder affecting ~80,000 individuals worldwide, is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein present at the apical membrane of epithelial cells. This is the only member of the ATPbinding cassette (ABC) transporter family, functioning as a channel, actually a cAMP-dependent chloride (Cl -)/ bicarbonate (HCO 3 -) channel. It consists of two membrane-spanning domains (MSD1/2), two nucleotide binding domains (NBD1/2) and a cytoplasmic regulatory domain (RD), which is unique to CFTR to represent critical folding conformational sites [3] [4] [5] important for the gating and maturation of the CFTR protein 5, 6 .
Although >2,000 CFTR gene mutations were reported (http://www.genet.sickkids.on.ca/cftr/app), one mutation F508del occurs in 85% of CF patients. This NBD1 mutant fails to traffic to the plasma membrane (PM) due to protein misfolding and retention by the endoplasmic reticulum quality control (ERQC) that targets it to premature proteasomal degradation. F508del-CFTR folding is a complex and inefficient process but it can be rescued, at least partially, by several treatments. These include low temperature incubation 7 , genetic revertants 4, 5, [8] [9] [10] [11] [12] [13] or pharmacological agents, like "corrector" VX-809 (lumacaftor) 14 , one of the first CFTR modulator drugs to receive FDA-approved in combination with potentiator VX-770/ivacaftor 1 . Determining the additive/ synergistic rescue of F508del-CFTR by small molecules correctors together with other rescuing agents/revertants is very valuable to determine the mechanism of action (MoA) of these CFTR modulators 5 .
Comparative studies of CFTR with other ABC transporters are very powerful to understand the uniqueness of some of its regions, their influence on CFTR maturation and function as well as how they affect distinctive binding of CFTR to modulator drugs. Two such unique regions are present in NBD1 of CFTR, which are absent in NBDs of other ABC transporters (Fig.S1 ) -the regulatory extension (RE) and regulatory insertion (RI). Both regions were described as highly conformationally dynamic 3, 16 following PKA phosphorylation at certain ( Ser) 18, 19 . Importantly, removal the 32-amino acid RI (ΔRI) was reported to rescue traffic of F508del-CFTR 13 .
Our first goal here was to assess the impact of removing the 30-amino acid RE (ΔRE) alone or jointly with ΔRI on the traffic of F508del-CFTR. Secondly, we aimed to evaluate how RE and or RI removal from F508del-CFTR influences the rescue of this mutant by genetic revertants. Our third and final 1 www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm453565.htm
Role of regulatory extension on CFTR stability.
4 goal was to determine how the traffic and function of these combined variants of F508del-CFTR (ΔRE, ΔRI plus genetic revertants) are rescued by CFTR modulator drugs VX-809 (corrector) and VX-770 (potentiator) to gain further insight into their MoA.
Our data show that although F508del-CFTR without RE did not traffic to the PM, it showed a dramatic stabilization of its immature form (evidencing a turnover rate ~3 x lower than that of wt-CFTR, being the turnover of F508del-CFTR itself is 2x faster vs. wt-CFTR). Results also show that, while ΔRI further increased processing of F508del-CFTR with revertants to almost wt-CFTR levels, RE removal completely abolished their processing, thus highlighting the different impact of the two dynamic regions on revertant-rescued F508del-CFTR. Most strikingly, although VX-809 rescued ΔRI-F508del-CFTR and ΔRE-ΔRI-F508del-CFTR processing to wt-CFTR levels, nevertheless to achieve maximal function of F508del-CFTR, removal of just RI was insufficient, as both RI and RE had to be absent from F508del-CFTR. These data indicate that removal of these two regions has a positive effect on the rescuing efficacy of F508del-CFTR by CFTR modulators.
Role of regulatory extension on CFTR stability. . All the constructs were produced using full length wt-CFTR and F508del-CFTR.
BHK cells lines expressing
-CFTR were produced and cultured as previously described 11 . Cells were cultured in DMEM/F-12 medium containing 5% (v/v) FBS and 500µM of methotrexate. For some experiments, cells were incubated with 3µM VX-809 or with the equivalent concentration of DMSO (Control) for 48h at 37ºC.
Western blot
To study the effect of removal of regulatory extension (RE) and or regulatory insertion (RI) in combination with genetic revertants and VX-809, cells were incubated for 48h at 37ºC with 3µM VX-809. After incubation, cells were lysed and extracts analysed by Western blot (WB) using the anti-CFTR antibody (Ab) 596 or anti-calnexin Ab as a loading control. Score corresponds to the percentage of band C to total CFTR (bands B+C) as normalized to the same ratio in samples from wt-CFTR expressing cells. Blot images were acquired using BioRad ChemiDoc XRC+ imaging system and band intensities were measured using Image Lab analysis software.
Pulse-chase and immunoprecipitation
BHK cells lines stably expressing CFTR variants were starved for 30 min in methionine-free α-modified Eagle's medium or minimal essential medium and then pulsed for 30min in the same medium supplemented with 100µCi/ml [ anti-CFTR antibody in independent experiments and Protein G-agarose or Protein A-Sepharose beads. Immunoprecipitated proteins were eluted from the beads with sample buffer for 1h at room temperature and then electrophoretically separated on 7% (w/v) polyacrylamide gels. Gels were pre-fixed in methanol/acetic acid (30:10, v/v), washed in water and, for fluorography, soaked in 1M sodium salicylate for 60 min. After drying at 80°C for 2h, gels were exposed to X-ray films and further analysed and quantified by densitometry.
Iodide efflux
CFTR-mediated iodide effluxes were measured at room temperature using the cAMP agonist forskolin (Fsk 10µM) and the CFTR potentiator genistein (Gen, 50µM) or VX-770 (10µM) and Gen (50µM).
Biochemical determination of the plasma membrane levels of CFTR
To determine plasma membrane levels of CFTR protein, we performed cell surface biotinylation in BHK cells cultured on permeable growth supports or tissue culture plates using cell membrane impermeable EZ-Link™ Sulfo-NHS-SS-Biotin, followed by cell lysis in buffer containing 25 mM HEPES, pH 8.0, 1% (v/v) Triton, 10% glycerol (v/v), and Complete Protease Inhibitor Mixture, as described previously 23, 24 . Biotinylated proteins were isolated by streptavidin-agarose beads, eluted into SDSsample buffer, and separated by 7.5% (w/v) SDS-PAGE.
Multiple sequence alignment
Sequences for NBD domains of ABC transporters were obtained from Uniprot 25 (human and mouse CFTR) or the PDB 26 (1B0U, 1L2T, 1G29, 1G6H, 1JJ7). Alignments were performed with Jalview 27 using the T-Coffee 28 algorithm using the default parameters.
Data and Statistical analyses
The data and statistical analyses used in this study comply with the recommendations on experimental design and data analysis in pharmacology (Curtis et al., 2015) . Quantitative results are shown as mean±SEM of n observations. To compare two sets of data, Student t-test was used and differences considered to be significant for p-values ≤ 0.05. In Western blotting (Figures 1-3 ), pulse chase ( Figures 4, S3) ; cell surface biotinylation ( Figure 4 ) and in iodide efflux studies ( Role of regulatory extension on CFTR stability.
8

RESULTS
Removal of short regulatory extension (RE S ) alone or with regulatory insertion (RI) has no impact on
F508del-CFTR processing
The impact of deleting RE S -short RE (Δ 654 Ser-Gly 673 , Figure S1 ) was first assessed, either alone or together with RI in its short and long variants (ΔRI S , ΔRI L ), on the in vivo processing of wt-and F508del-CFTR by Western blot (WB) of BHK cells stably expressing such variants (Fig.1A ,D,E; Table1).
Removal of RE S had no impact on processing of either F508del-CFTR or wt-CFTR (Fig.1A, lanes 5,10; Table1), despite that the immature form of ΔRE S -F508del-CFTR appeared consistently at increased levels vs. those of F508del-CFTR (Fig.1A, lanes 5,2) . Figure S1 ) had no impact on ΔRE S -F508del-CFTR processing (Fig.1A , lanes 6,7; Fig.1E ; Table1). So in summary, removal of RE S jointly with RI S or RI L had no effect on F508del-CFTR processing.
Interestingly, when RE S and RI S , were jointly removed from wt-CFTR, its processing was significantly reduced to 54±9%, while ΔRE S jointly with ΔRI L caused no impact (Fig.1A , lanes11,12, respectively; Fig.1D ; Table1). Again, these data were equivalent to removal of ΔRI S or ΔRI L alone on wt-CFTR processing (Fig.1A , lanes8,9; Fig.1E ; Table1).
Control
VX-809 Control VX-809
CFTR variant % to wt % to wt % to wt % to wt -100 ± 1 103 ± 1 8 ± 1 17 ± 2 -98 ± 2 100 ± 1 3 ± 2 9 ± 4 ∆RI S 54 ± 9 93 ± 3 7 ± 2 20 ± 4 ∆RI L 100 ± 1 97 ± 2 71 ± 3 96 ± 2 R1070W 71 ± 6 90 ± 3 33 ± 7 26 ± 6 G550E 101 ± 1 102 ± 1 37 ± 5 39 ± 4 -88 ± 5 87 ± 3 9 ± 2 8 ± 2 ∆H9 55 ± 3 69 ± 3 0 ± 0 0 ± 0 72 ± 4 69 ± 3 1 ± 0 0 ± 0 -44 ± 2 90 ± 3 3 ± 2 4 ± 3 R1070W 11 ± 3 56 ± 8 2 ± 0 4 ± 2 G550E 82 ± 3 98 ± 1 6 ± 4 5 ± 3 
R1070W
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The differential effect caused by removal of RI S vs RI L on F508del-and wt-CFTR emphasize the importance of those 8 N-term ( 404 Gly-Ala
412
) and 7 C-term (Leu 428 -Leu 435 ) amino acid residues that differ between those 2 RI regions for the folding and processing of CFTR.
Simultaneous removal of long regulatory extension (RE L ) and helix H9 significantly reduces wt-CFTR processing but increases levels of F508del-CFTR immature form
Next, we assessed the impact of removing the long version of RE -RE L (Δ , Figure S1 ) can be considered to be part of this longer RE region 22 since it interacts with RE ( Figure S2 ), we also tested the effect of removing helix H9 jointly with ΔRE L . Deletion of both H9 (ΔH9) and RE L further decreased the residual processing of ΔRE L -F508del-CFTR from 9±2 to 0±0% and in fact the same happened for ΔH9 alone ( Fig.2a , lanes 8,6, respectively). Curiously, however, levels of immature F508del-CFTR were significantly increased when both RE L and H9 were removed ( Fig.2A, lane8 ), similarly to ΔRE S -
For wt-CFTR, ΔRE L -ΔH9 also led to a decrease in processing (55±3%), which was more pronounced than for ΔRE L alone, but interestingly removal of H9 helix alone only reduced processing to 72±4%
( Fig.2A , lanes 7,5, respectively).
ΔRI S , but not ΔRE S , abolishes the plasma membrane rescue of F508del-CFTR by revertants
In order to test whether the stabilized immature form of ΔRE S -F508del-CFTR could be rescued to mature form, we next tested the effects of removing the RE S from F508del-CFTR with R1070W and G550E revertants. Indeed, both the R1070W and G550E revertants rescued ΔRE S -F508del-CFTR to 33±7% and 37±5%, respectively ( Interestingly, the impaired processing of ΔRI S -wt-CFTR (44±2%) was significantly rescued by G550E
(to 82±3%), but curiously it was further reduced by R1070W (to 11%) i.e., close to levels of F508del-CFTR processing (Fig.1B, lanes8,4 ; Table1). Of note that R1070W alone also reduced wt-CFTR Role of regulatory extension on CFTR stability.
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processing to 69±7%, but this reduction could be compensated by the removal of RI L (92±2%) (Fig.1B , lanes 3,5; Table1), while G550E alone caused no effect on wt-CFTR processing (Fig.1B,   lane7 ).
ΔRI L synergises with VX-809, but not with revertants to rescue ΔRE S -F508del-CFTR processing
To further test how the stabilized immature form of ΔRE S -F508del-CFTR could be pharmacologically rescued, we then assessed the impact of corrector VX-809 (which per se promotes maturation of the F508del-CFTR) on the processing of this and of the other variants, to obtain structural insight on the effects of this novel drug. Although ΔRE S -F508del-CFTR could not be rescued by VX-809, data show that this small molecule was able to rescue ΔRI S -ΔRE S -F508del-CFTR (from 7±2% to 20±4%) and further increased processing of ΔRI L -ΔRE S -F508del-CFTR to wt-CFTR levels (from 71±3% to 96±2%) (Fig.3A , lanes 6,7; Fig.3E ; Table1). These data suggest a strong synergistic effect between VX-809 and ΔRI L (and with ΔRI S , albeit to a lesser extent) to rescue ΔRE S -F508del-CFTR processing. This is particularly interesting because VX-809 did not rescue processing of the ΔRE S -, nor ΔRI S -F508del-CFTR variants (Fig.3A , lanes 5,3; Table1) while it recovered the processing of ΔRI L -F508del-CFTR to wt-CFTR levels ( Fig.3A, lane4 ; Table1). Notably, VX-809 was able to almost completely revert processing impairment of ΔRI S -wt-CFTR and ΔRI S -ΔRE S -CFTR (from 44±2% and 54±9%) to 90±3% and 93±3%, respectively (Fig.3A, lanes8,11 ; Fig.3D ; Table1).
Strikingly, VX-809 had no effect on processing of ΔRE S -F508del-CFTR with R1070W or G550E (Fig.3C , lanes 6,10; Fig.3E ; Table1), while it further rescued processing of F508del-CFTR variants with R1070W or G550E alone to 46±4% and 73±6%, respectively (Fig.3C , lanes 3,7; Fig.3E ; Table 1), as   reported   5 . Similarly, VX-809 caused no significant further rescue on the processing of ΔRI L -F508del-CFTR with those revertants, but these variants already had processing levels close to those of wt-CFTR (Fig.3C , lanes 5, 9; Fig.3E ; Table 1 ). Interestingly, the impaired processing of ΔRE S -R1070W-wt-CFTR (71±6%) was also reverted by VX-809 to 90±3% (Fig.3B , lane 6; Table 1 ).
Corrector VX-809 failed to rescue any of the ΔRE L -, ΔH9-and ΔRE L -ΔH9-F508del-CFTR variants (Fig.2B, C) , while significantly increasing the processing of the ΔRE L -ΔH9-wt-CFTR from 55±3% to 69±3% (Fig.2B, lane 7; Fig.2C ).
ΔRI L -ΔRE S -F508del-CFTR levels at the plasma membrane are equivalent to those of wt-CFTR
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To determine the fraction of the above CFTR variants that localize to the PM, we used quantitative cell surface biotinylation. These data showed that PM levels of ΔRI L -ΔRE S -F508del-CFTR were equivalent to those of wt-CFTR, while those of ΔRI L -F508del-CFTR were significantly lower ( F508del-CFTR to levels that are significantly higher than those of wt-CFTR (Fig.4A, lanes 2, 9, Fig.4B ).
This compound also significantly increased PM levels of ΔRI L -F508del-CFTR to similar levels of wt-CFTR (Fig.4A, lanes 2, 8; Fig.4B ).
Given the very significant stabilization of immature ΔRE S -F508del-CFTR (Fig.1A) , next, we determined how removal of ΔRE S affected the processing efficiency and the turnover of the F508del-and ΔRI LF508del-CFTR variants. To this end, we performed pulse-chase experiments (Fig.4C, D ) and indeed our results revealed that ΔRE S very significantly stabilized immature F508del-CFTR not just relatively to F508del-CFTR but to levels even significantly higher than those of wt-CFTR (Fig.4C, D) .
Interestingly, this stabilizing effect was no longer significant for ΔRI L -ΔRE S -F508del-CFTR nor for ΔRI LF508del-CFTR, the latter being equivalent to wt-CFTR (Fig.4C, D) . Removal of RI S from F508del-CFTR did not stabilize its turnover (data not shown). As to removal of either RE S or RI S from wt-CFTR, it did not affect the processing efficiency or the turnover vs wt-CFTR ( Figure S3 ).
VX-809 jointly with RE and RI removal completely restored F508del-CFTR function as chloride channel
To investigate the channel function of the ΔRE S -and ΔRI L -F508del-CFTR variants, we used the iodide efflux technique. Removal of RE S alone had no impact on F508del-CFTR function ( Fig.5A ; black dash line in Figure S4B ) as expected from the lack of processed form for this variant (Fig.1A) . However, when RE S and RI L were removed jointly from F508del-CFTR, functional levels reached 78±7% of wt-CFTR ( Fig.5A, C ; black dotted line in Figure S4B ). As to removal of RI L alone from F508del-CFTR, it restored function to 92±7% of wt-CFTR ( Fig.5A, C ; black line in Figure S4B ), as described
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. Also, the delay in peak response observed for F508del-CFTR (min=4) vs wt-CFTR (min=2), was partially corrected (to min=3) both by removal of RI L alone from F508del-CFTR or together with RE S (Fig.5C ; Figure S4B , black line and dotted line).
Introduction of G550E and R1070W revertants into the ΔRI L -F508del-CFTR variant slightly but not significantly decreased its function from 92±7% to 71±8% and 76±8%, respectively ( Fig.5A, C ; black lines in Figure S4C , D), in parallel to the respective processing levels (Fig.1) . In fact, these variants showed higher activity levels than the revertants containing RI L (29±3% and 56±6%, respectively).
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Interestingly however, both G550E-and R1070W-ΔRI L -F508del-CFTR fully corrected (to min=2) the delay in peak response of F508del-CFTR, which was still partially present in ΔRI L -and ΔRI L -RE S -
F508del-CFTR (min=3).
The effect of VX-809 (3µM, 48h at 37ºC) was also examined at functional level on the ΔRE S -, ΔRI L -ΔRE S -and ΔRI L -F508del-CFTR variants. Strikingly VX-809 caused an increase in ΔRE S -ΔRI L -F508del-CFTR function (84±8% of wt-CFTR) which was parallel to the observed increase in PM expression ( Fig.4 ; Fig.5A , C; black dotted line in Figure S4F ). Also, ΔRE S -ΔRI L -F508del-CFTR fully corrected (to min=2) the delay in peak response of F508del-CFTR which was still partially present in ΔRI L -and ΔRI L -
In contrast to the observed increase in processing, VX-809 caused no significant increase in the function of ΔRI L -F508del-CFTR and actually a slight, but not significant decrease was observed and there was still the same delay in peak response ( Fig.5A , C; black line in Figure S4F ).
A similar slight decrease in function was observed for VX-809 on the ΔRI L -R1070W-F508del-CFTR variant ( Fig.5A, C ; black line in Figure S4H ), but the most striking result was observed for the significant decrease caused by VX-809 on function of ΔRI L -G550E-F508del from 76±8 to 41±3%
( Fig.5A, C ; black line in Figure S4G ). Nevertheless both revertant variants of ΔRI L -F508del-CFTR showed no change in peak response which was still the same as wt-CFTR (min=2).
VX-770-stimulated currents of CFTR variants are dramatically decreased by ΔRI L but not by ΔRI L -ΔRE S
Given the interesting and diverse results observed for the ΔRE S and ΔRI L under VX-809, next we tested the effects of potentiator VX-770 (Ivacaftor), an approved drug for CF patients with gating mutations (Fig.5B ) on these variants and in combination with VX-809, for F508del/F508del patents.
Most strikingly, our data show that VX-770/Fsk significantly decreased the function of ΔRI L -F508del-CFTR vs potentiation by Gen/Fsk (Fig.5B, C ) from 92±7% to 58±7% of wt-CFTR ( Fig.5B, C ; black line in Figure S4J ). As ΔRE S -F508del-CFTR was not processed, we did not test the effect of VX-770 on this variant, but when the ΔRE S -ΔRI L -F508del-CFTR variant was assessed for its function after acute application of VX-770 with Fsk, an increase in function (to 87±3% of wt-CFTR) was observed vs its function under Gen/Fsk (78±7% of wt-CFTR) ( Fig.5B, C ; black dotted line in Figure S4J ).
The most dramatic result, however, was observed for the ΔRI L -G550E-F508del-CFTR variant which under VX-770/Fsk only had 4±1% function of wt-CFTR, while under Gen/Fsk it had 76±8% ( Fig.5B, C; black line in Figure S4K ). For ΔRI L -R1070W-F508del-CFTR this decrease was not observed (Fig.5B, C; Role of regulatory extension on CFTR stability.
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black line in Figure S4L ), and in fact this variant had a slightly higher function under VX-770 stimulation (72±4%) than ΔRI L -F508del-CFTR (58±7%) (Fig.5B , C, black line in Figure S4H ).
The delay in peak response of F508del-vs. wt-CFTR was not corrected for ΔRI L -F508del-CFTR (min=3), but it was corrected for ΔRI L -ΔRE S -F508del-CFTR (min=2) (black and dotted black lines in Figure S4J , respectively). Curiously, on the other hand ΔRI L -R1070W-F508del-CFTR showed the quickest peak response (at min=1), in contrast to either R1070W-F508del-CFTR or ΔRI L -F508del-CFTR, both at min=3.
Similarly, VX-770 also significantly decreased the function of ΔRI L -wt-CFTR from 127±15% under Gen to 57±6% ( Figure S5 ).
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Discussion
The main goal of this study was to understand how the removal of the regulatory extension (ΔRE) alone or with the regulatory insertion (ΔRI)-two highly conformationally dynamic regions -impacted on the rescue of F508del-CFTR processing and function by two compounds -VX-809 and VX-770 -which in combination were recently approved o clinically treat F508del-homozygous patients.
Indeed, CFTR is the sole ABC that functions as a channel and thus, these highly dynamic RE and RI regions which are absent in other ABC transporters, may be of high relevance to understand how CFTR differs from other ABCs, namely in its function as a channel.
These regions RE and RI were originally suggested to be positioned to impede formation of the NBD1-NBD2 dimer required for channel gating 16, 17 . Indeed, both RI and RE were shown to be mobile elements in solution that bind transiently to the core of NBD in the ß-sheet and α/ß subdomains of Although this region was absent from the solved CFTR-NBD1 crystal structure 17 , it was described as a helix packing against NBD1 at the NBD1:NBD2 interface and NMR data showed it has significant conformational flexibility 3, 20 . .
Impact of RE and RI on CFTR processing and function
Our data shown here on CFTR variants depleted of different versions of the RE dynamic region demonstrate that unlike RI deletion, removal of short RE -ΔRE S (Δ 654 Ser-Gly 673 ) did not per se rescue F508del-CFTR processing. Nevertheless, ΔRE S dramatically stabilized the immature form of F508del-CFTR (see Fig.6 ). In fact, our pulse-chase experiments show that the immature form of ΔRE S -F508del-CFTR exhibits a turnover rate which is ~2.7 fold lower than that of wt-CFTR. Of note, when
Aleksandrov et al removed the dynamic region RI from F508del-CFTR they found a dramatic increase further reduced its function (from 92% to 78%).
The latter findings on function of ΔRE S -wt-CFTR and ΔRE S -ΔRI L -F508del-CFTR were somewhat surprising since the RE was previously described to impede putative NBD1:NBD2 dimerization that is required for channel gating 21 . Accordingly, an increase in CFTR activity would be expected upon Ala-Leu 428 ) significantly reduced wt-CFTR processing to less than half of its normal levels, while not rescuing F508del-CFTR processing, thus being essential for CFTR proper folding. This is in contrast to removal of long RI (ΔRI L ) which led to 78% processing F508del-CFTR, as reported 13 but without impact on wt-CFTR. These data indicate that those 8/ 7 amino acid residues at the N-term/ C-term of RI S (and absent in RI L ) impair the folding efficiency and processing of both wt-and F508del-CFTR.
The recently published cryo-EM structure of human CFTR 33 indicates that these regions are structurally disordered. Consistently, the RI loop in NBD1 is described in the of zebrafish CFTR cryostructure to contribute to the amorphous density that is observed between NBD1 and the elbow helix of TMD2 
Effect of VX-809 on F508del-CFTR variants lacking RE and RI
As for rescue of CFTR variants lacking RE and RI by CFTR modulators, VX-809 restored the processing of both ΔRE S -ΔRI L -and ΔRI L -F508del-CFTR variants equally well and to wt-CFTR levels (from 71-78%
to 92-96%. These data suggest a strong synergistic effect between VX-809 and ΔRI L to rescue ΔRE SF508del-CFTR processing and thus some possible interference of the regulatory insertion with VX-809 binding to F508del-CFTR (see Fig.6 ). Indeed, although previous studies 5, 36, 37 suggested putative binding of VX-809 to NBD1:MSD2 (ICL4) interface (see Fig.6 ), they also suggested scope for further F508del-CFTR correction at distinct conformational sites, so data shown here suggest that VX-809 may also bind to the regulatory insertion.
Interestingly, the processing defect of ΔRI S -wt-CFTR (but not of ΔRI S -F508del-CFTR) was rescuable by VX-809 to 90%, indicating that the amino acid stretches of the RI L that remain present in RI S do not affect the rescue of ΔRI S -wt-CFTR but preclude rescue of F508del-CFTR by VX-809.
We also tested here the impact of removing helix 9 (H9) which precedes the RE ( is present, ΔRE L -wt-CFTR processing appears to be favoured by VX-809, suggesting some synergy of this small molecule with H9 helix to correct the conformational defect(s) caused by ΔRE L on wt-CFTR.
These data are in contrast to ΔH9-F508del-CFTR which exhibits 0% processing with or without ΔRE L and no rescue by VX-809.
Very strikingly, and in contrast to its effect on processing, was the effect of ΔRI L on the VX-770 stimulated currents which were decreased by almost half vs those stimulated by Gen/Fsk (92% to 58%). These data seem to indicate that the absence of the regulatory insertion could impair (and its presence favour) binding of VX-770 to CFTR (see Fig.6) . Surprisingly, the removal of RE s from ΔRI LF508del-CFTR could correct this defect and restore the maximal function by VX-770 (see Fig.6 ).
Indeed, under VX-770, ΔRE S -ΔRI L -F508del-CFTR exhibited significantly higher activity (87%) than ΔRI L -F508del-CFTR (58%). In contrast, removal of RE S from wt-CFTR significantly reduced its function vs that of wt-CFTR (down to 70%) but had no effect on processing.
Impact of F508del-revertants on CFTR variants lacking RE and RI
Another goal of the present study was to assess how presence of the F508del-CFTR revertants G550E and R1070W 5,10,11 influence variants without RE and RI. Remarkably, our data show that the presence of either of these revertants did not affect ΔRE S -F508del-CFTR processing, but both of them further increased processing (but not function) of ΔRI L -F508del-CFTR to almost levels of wt-CFTR: 92-96% (G550E) and 71-76% (R1070W).
In contrast, removal of RI S from either of these F508del-CFTR revertants completely abolished their processing, emphasizing how important the different residues between RI S and RI L are for F508del-CFTR conformers partially rescued by the revertants.
Regarding wt-CFTR processing, G550E (at the NBD1:NBD2 dimer interface) also partially recovered the negative effect caused by RI S removal. In contrast, R1070W (at the NBD1:ICL4 interface), negatively affected processing of wt-CFTR (to 69%) and of ΔRI S -wt-CFTR (from 44% to 11%), while Trp residues. It is, nevertheless curious that R1070W affect more the processing ΔRI Swt-CFTR than wt-CFTR, to levels of F508del-CFTR, suggesting that both changes affect the same region of the molecule. Rescue of both R1070W-wt-CFTR and R1070W-ΔRI S -wt-CFTR by VX-809 further supports this concept.
The most striking effect of ΔRI L however, was the almost complete abolition of VX-770-stimulated current of G550E-F508del-CFTR to levels even lower than those observed for ΔRI L -F508del-CFTR (see above). It was suggested that VX-770 binds directly to CFTR to the MSDs (although it is not defined the exact binding site), in phosphorylation-dependent but ATP-independent manner and away from the canonical catalytic site 39, 40 . Both RD and RI were suggested by Eckford and colleagues as putative binding regions for VX-770 39 . Nevertheless, the pharmacological effect of VX-770 remains robust in the absence of the RD 40 and here we demonstrate that it does indeed require RI since VX-770 is unable to stimulate either ΔRI L -F508del-CFTR or ΔRI L -G550E-F508del-CFTR (see Fig.6 ).
Overall, our data show that while the presence of the regulatory insertion seems to be precluding full rescue of F508del-CFTR processing by VX-809, this region appears essential to rescue its function Role of regulatory extension on CFTR stability.
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by VX-770, thus suggesting some contradictory role in rescue of F508del-CFTR by these two modulators. Nevertheless, this negative impact of RI L removal on VX-770-stimulated currents on F508del-CFTR can be compensated by deletion of the regulatory extension which also leads to the stabilization of this mutant. We thus propose that, despite both these regions being conformationally active, RI precludes F508del-CFTR processing while RE affects mostly its stability and channel opening. 
(5) 
